These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. In vitro evaluation of actively targetable superparamagnetic nanoparticles to the folate receptor positive cancer cells. Nasiri R; Hamzehalipour Almaki J; Idris AB; Abdul Majid FA; Nasiri M; Salouti M; Irfan M; Amini N; Marvibaigi M Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():1147-58. PubMed ID: 27612812 [TBL] [Abstract][Full Text] [Related]
43. Folate-polyethyleneimine functionalized mesoporous carbon nanoparticles for enhancing oral bioavailability of paclitaxel. Wan L; Wang X; Zhu W; Zhang C; Song A; Sun C; Jiang T; Wang S Int J Pharm; 2015 Apr; 484(1-2):207-17. PubMed ID: 25724138 [TBL] [Abstract][Full Text] [Related]
44. Targeted antitumor comparison study between dopamine self-polymerization and traditional synthesis for nanoparticle surface modification in drug delivery. Zhang M; Zou Y; Zuo C; Ao H; Guo Y; Wang X; Han M Nanotechnology; 2021 May; 32(30):. PubMed ID: 33862617 [TBL] [Abstract][Full Text] [Related]
45. Spatiotemporally programmable surface engineered nanoparticles for effective anticancer drug delivery. Ahmed A; Yu H; Han D; Rao J; Ding Y; Hu Y Macromol Biosci; 2014 Nov; 14(11):1652-62. PubMed ID: 25181029 [TBL] [Abstract][Full Text] [Related]
46. Anti-tumor efficacy of polymer-platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice. Xue Y; Tang X; Huang J; Zhang X; Yu J; Zhang Y; Gui S Colloids Surf B Biointerfaces; 2011 Jul; 85(2):280-8. PubMed ID: 21435846 [TBL] [Abstract][Full Text] [Related]
47. Design and construction of multifunctional hyperbranched polymers coated magnetite nanoparticles for both targeting magnetic resonance imaging and cancer therapy. Mashhadi Malekzadeh A; Ramazani A; Tabatabaei Rezaei SJ; Niknejad H J Colloid Interface Sci; 2017 Mar; 490():64-73. PubMed ID: 27870961 [TBL] [Abstract][Full Text] [Related]
48. Folate-decorated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting delivery: optimization and in vivo antitumor activity. Zhang C; Zhang Z; Zhao L Drug Deliv; 2016 Jun; 23(5):1830-7. PubMed ID: 26652055 [TBL] [Abstract][Full Text] [Related]
49. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery. Wu Y; Chu Q; Tan S; Zhuang X; Bao Y; Wu T; Zhang Z Int J Nanomedicine; 2015; 10():5219-35. PubMed ID: 26316751 [TBL] [Abstract][Full Text] [Related]
50. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo. Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391 [TBL] [Abstract][Full Text] [Related]
51. Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer. Nasri N; Saharkhiz S; Dini G; Yousefnia S Int J Pharm; 2023 Dec; 648():123606. PubMed ID: 37972671 [TBL] [Abstract][Full Text] [Related]
52. Folate-mediated solid-liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol). Wu L; Tang C; Yin C Drug Dev Ind Pharm; 2010 Apr; 36(4):439-48. PubMed ID: 19824865 [TBL] [Abstract][Full Text] [Related]
53. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity. Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908 [TBL] [Abstract][Full Text] [Related]
54. Preparation and In Vitro/Vivo Evaluation of Folate-conjugated Pluronic F87-PLGA/TPGS Mixed Nanoparticles for Targeted Drug Delivery. Wu T; Gong Y; Li Z; Li Y; Xiong X Curr Drug Deliv; 2021; 18(10):1505-1514. PubMed ID: 33845742 [TBL] [Abstract][Full Text] [Related]
55. Folic acid-conjugated superparamagnetic iron oxide nanoparticles for tumor-targeting MR imaging. Li L; Gao F; Jiang W; Wu X; Cai Y; Tang J; Gao X; Gao F Drug Deliv; 2016 Jun; 23(5):1726-33. PubMed ID: 25715808 [TBL] [Abstract][Full Text] [Related]
56. Effects of poly(ethylene glycol) grafting density on the tumor targeting efficacy of nanoparticles with ligand modification. Zhang S; Tang C; Yin C Drug Deliv; 2015 Feb; 22(2):182-90. PubMed ID: 24215373 [TBL] [Abstract][Full Text] [Related]
57. Hypocrellin B-loaded, folate-conjugated polymeric micelle for intraperitoneal targeting of ovarian cancer in vitro and in vivo. Li J; Yao S; Wang K; Lu Z; Su X; Li L; Yuan C; Feng J; Yan S; Kong B; Song K Cancer Sci; 2018 Jun; 109(6):1958-1969. PubMed ID: 29617063 [TBL] [Abstract][Full Text] [Related]
58. Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy. Zhi D; Yang T; Yang J; Fu S; Zhang S Acta Biomater; 2020 Jan; 102():13-34. PubMed ID: 31759124 [TBL] [Abstract][Full Text] [Related]
59. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles. Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749 [TBL] [Abstract][Full Text] [Related]